Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men.

ABSTRACT:

Unlabelled

Melatonin has anticarcinogenic properties in experimental models. We undertook a case-cohort study of 928 Icelandic men without prostate cancer (PCa) nested within the Age, Gene/Environment Susceptibility (AGES)-Reykjavik cohort to investigate the prospective association between first morning-void urinary 6-sulfatoxymelatonin (aMT6s) levels and the subsequent risk for PCa, under the hypothesis that men with lower aMT6s levels have an increased risk for advanced PCa. We used weighted Cox proportional hazards models to assess the association between first morning-void aMT6s levels and PCa risk, adjusting for potential confounders. A total of 111 men were diagnosed with incident PCa, including 24 with advanced disease. Men who reported sleep problems at baseline had lower m

SUBMITTER: Sigurdardottir LG 

PROVIDER: S-EPMC4318783 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature